-
公开(公告)号:US20080200671A1
公开(公告)日:2008-08-21
申请号:US11939023
申请日:2007-11-13
IPC分类号: C07D267/00
CPC分类号: C07D491/04
摘要: The invention relates to an orthorhombic crystal form of compound trans-5-chloro-2,3,3a, 12b-tetrahydro-2-methyl-1H-dibenz [2,3:6,7] oxepino [4,5-c] pyrrole (Z)-2-butenedioate, to methods for the preparation of this crystal form and to pharmaceutical compositions comprising an orthorhombic crystal form.
摘要翻译: 本发明涉及反式-5-氯-2,3,3a,12b-四氢-2-甲基-1H-二苯并[2,3:6,7]氧杂环庚烯并[4,5-c] 吡咯(Z)-2-丁烯二酸盐,制备该晶型的方法和包含斜方晶体形式的药物组合物。
-
公开(公告)号:US08022228B2
公开(公告)日:2011-09-20
申请号:US11939023
申请日:2007-11-13
IPC分类号: C07J73/00 , C07D313/00
CPC分类号: C07D491/04
摘要: The invention relates to an orthorhombic crystal form of compound trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole(Z)-2-butenedioate, to methods for the preparation of this crystal form and to pharmaceutical compositions comprising an orthorhombic crystal form.
摘要翻译: 本发明涉及反-5-氯-2,3,3a,12b-四氢-2-甲基-1H-二苯并[2,3:6,7]氧杂环庚烯并[4,5-c]的正交晶体形式, 吡咯(Z)-2-丁烯二酸盐,制备该晶型的方法和包含斜方晶体形式的药物组合物。
-
公开(公告)号:US07741358B2
公开(公告)日:2010-06-22
申请号:US11399204
申请日:2006-04-06
CPC分类号: C07D491/04
摘要: The invention relates to an orthorhombic crystal form of compound trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz [2,3:6,7]oxepino[4,5-c]pyrrole (Z)-2-butenedioate, to methods for the preparation of this crystal form and to pharmaceutical compositions comprising an orthorhombic crystal form.
摘要翻译: 本发明涉及反式-5-氯-2,3,3a,12b-四氢-2-甲基-1H-二苯并[2,3:6,7]氧杂环庚烯并[4,5-c] 吡咯(Z)-2-丁烯二酸盐,制备该晶型的方法和包含斜方晶体形式的药物组合物。
-
-